4.8 Article

Heart- and muscle-derived signaling system dependent on MED13 and Wingless controls obesity in Drosophila

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1409427111

关键词

Skuld; kohtalo; myokines; metabolic syndrome

资金

  1. Transgenic RNAi Project at Harvard Medical School [National Institutes of Health (NIH)/National Institute of General Medical Sciences] [R01-GM084947]
  2. NIH [HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401]
  3. Cancer Prevention and Research Institute of Texas
  4. Robert A. Welch Foundation [1-0025]

向作者/读者索取更多资源

Obesity develops in response to an imbalance of energy homeostasis and whole-body metabolism. Muscle plays a central role in the control of energy homeostasis through consumption of energy and signaling to adipose tissue. We reported previously that MED13, a subunit of the Mediator complex, acts in the heart to control obesity in mice. To further explore the generality and mechanistic basis of this observation, we investigated the potential influence of MED13 expression in heart and muscle on the susceptibility of Drosophila to obesity. Here, we show that heart/muscle-specific knockdown of MED13 or MED12, another Mediator subunit, increases susceptibility to obesity in adult flies. To identify possible muscle-secreted obesity regulators, we performed an RNAi-based genetic screen of 150 genes that encode secreted proteins and found that Wingless inhibition also caused obesity. Consistent with these findings, muscle-specific inhibition of Armadillo, the downstream transcriptional effector of the Wingless pathway, also evoked an obese phenotype in flies. Epistasis experiments further demonstrated that Wingless functions downstream of MED13 within a muscle-regulatory pathway. Together, these findings reveal an intertissue signaling system in which Wingless acts as an effector of MED13 in heart and muscle and suggest that Wingless-mediated cross-talk between striated muscle and adipose tissue controls obesity in Drosophila. This signaling system appears to represent an ancestral mechanism for the control of systemic energy homeostasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cell Biology

Direct reprogramming as a route to cardiac repair

Glynnis A. Garry, Rhonda Bassel-Duby, Eric N. Olson

Summary: Ischemic heart disease is the leading cause of morbidity and mortality worldwide, and finding new ways to promote cardiomyocyte regeneration is crucial. Direct reprogramming of cardiac fibroblasts into induced cardiac-like myocytes (iCMs) has shown promising potential, but there are challenges in reprogramming adult human fibroblasts.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2022)

Article Multidisciplinary Sciences

The cardiac-enriched microprotein mitolamban regulates mitochondrial respiratory complex assembly and function in mice

Catherine A. Makarewich, Amir Z. Munir, Svetlana Bezprozvannaya, Aaron M. Gibson, Soo Young Kim, Misty S. Martin-Sandoval, Thomas P. Mathews, Luke I. Szweda, Rhonda Bassel-Duby, Eric N. Olson

Summary: New evidence suggests that certain noncoding RNA molecules actually code for microproteins. By using comparative genomics, researchers identified a microprotein called Mtlbn that is abundantly expressed in the heart. Mtlbn localizes to the inner mitochondrial membrane and interacts with subunits of the electron transport chain and respiratory supercomplexes.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Cell Biology

RBPMS is an RNA-binding protein that mediates cardiomyocyte binucleation and cardiovascular development

Peiheng Gan, Zhaoning Wang, Maria Gabriela Morales, Yu Zhang, Rhonda Bassel-Duby, Ning Liu, Eric N. Olson

Summary: This study identified a genetic defect associated with noncompaction cardiomyopathy and revealed some underlying mechanisms. The loss of Rbpms gene led to premature cardiomyocyte binucleation and cell cycle arrest, in which Rbpms mediated the isoform switching of a specific protein.

DEVELOPMENTAL CELL (2022)

Article Medicine, Research & Experimental

Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice

Dileep R. Karri, Yu Zhang, Francesco Chemello, Yi-Li Min, Jian Huang, Jiwoong Kim, Pradeep P. A. Mammen, Lin Xu, Ning Liu, Rhonda Bassel-Duby, Eric N. Olson

Summary: This study demonstrates the long-term durability of CRISPR/Cas9 genome editing as a therapy for maintaining the integrity and function of DMD muscle, even under conditions of stress.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Cardiac & Cardiovascular Systems

CRISPR Modeling and Correction of Cardiovascular Disease

Ning Liu, Eric N. Olson

Summary: Cardiovascular disease is the leading cause of deaths and illnesses in developed countries. Mouse models have played a significant role in studying the complex signaling pathways, genetic and epigenetic regulations, and multicellular interactions involved in cardiovascular disease. The advent of CRISPR genome editing has revolutionized cardiovascular research, allowing for rapid modeling and potential genetic correction of disease-causing mutations.

CIRCULATION RESEARCH (2022)

Article Geriatrics & Gerontology

Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy

Mina Shahriyari, Md Rezaul Islam, Sadman M. Sakib, Malte Rinn, Anastasia Rika, Dennis Krueger, Lalit Kaurani, Verena Gisa, Mandy Winterhoff, Harithaa Anandakumar, Orr Shomroni, Matthias Schmidt, Gabriela Salinas, Andreas Unger, Wolfgang A. Linke, Jana Zschuentzsch, Jens Schmidt, Rhonda Bassel-Duby, Eric N. Olson, Andre Fischer, Wolfram-Hubertus Zimmermann, Malte Tiburcy

Summary: This study successfully established methods for deriving skeletal muscle cells from human pluripotent stem cells and engineered a functional human skeletal muscle organoid and engineered skeletal muscle with regeneration-competent satellite-like cells. Contractile performance of the engineered muscle was further enhanced by thyroid hormone treatment.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Article Medicine, Research & Experimental

A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing

Yu Zhang, Hui Li, Takahiko Nishiyama, John R. McAnally, Efrain Sanchez-Ortiz, Jian Huang, Pradeep P. A. Mammen, Rhonda Bassel-Duby, Eric N. Olson

Summary: In this study, a humanized DMD mouse model was created to evaluate the efficacy of CRISPR-Cas9 gene editing for DMD correction. The model successfully restored dystrophin expression and improved pathological features and muscle strength. This model provides a valuable tool for assessing clinically relevant gene editing strategies and advancing the therapeutic translation of CRISPR-Cas9 gene editing for DMD correction.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Cell Biology

Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy

Takahiko Nishiyama, Yu Zhang, Miao Cui, Hui Li, Efrain Sanchez-Ortiz, John R. McAnally, Wei Tan, Jiwoong Kim, Kenian Chen, Lin Xu, Rhonda Bassel-Duby, Eric N. Olson

Summary: Mutations in the RBM20 gene are a common cause of familial dilated cardiomyopathy. The study uses gene editing techniques to correct these mutations and demonstrates that correction can restore normal gene splicing and nuclear localization, while eliminating abnormal ribonucleoprotein granule formation. The effectiveness of this therapy is also validated in a mouse model.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Immunology

Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies

Ildiko Bock-Marquette, Klaudia Maar, Szabolcs Maar, Balint Lippai, Gabor Faskerti, Ferenc Gallyas, Eric N. Olson, Deepak Srivastava

Summary: Our dream of defeating the processes of organ damage and aging remains a challenge, and steps towards regenerating individual organs are considered significant. Through interconnecting our collective knowledge regarding aging and embryonic development, we propose to discover molecules that can effectively reverse cellular damage. Our results regarding Thymosin beta-4 (TB4) support this hypothesis, showing its potential to promote cardiac cell migration and survival, enhance myocyte survival and improve cardiac function, and activate epicardial progenitor cells.

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

Loss Of Function Of The Nuclear Envelope Protein LEMD2 Causes DNA Damage-dependent Cardiomyopathy

Xurde M. Caravia, Andres Ramirez-Martinez, Peiheng Gan, John R. McAnally, Rhonda Bassel-Duby, Ning Liu, Eric N. Olson

CIRCULATION RESEARCH (2022)

Article Medicine, Research & Experimental

Loss of function of the nuclear envelope protein LEMD2 causes DNA damage-dependent cardiomyopathy

Xurde M. Caravia, Andres Ramirez-Martinez, Peiheng Gan, Feng Wang, John R. McAnally, Lin Xu, Rhonda Bassel-Duby, Ning Liu, Eric N. Olson

Summary: Mutations in nuclear envelope proteins cause devastating genetic diseases that primarily affect the heart and skeletal muscle. This study reveals the essentiality of LEMD2 for genome stability and cardiac function, and uncovers its mechanistic association with human disease. Gene therapy targeting Lemd2 can rescue the disease phenotype.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

The Nuclear Transcription Factor Y Controls Cell-cycle And Metabolic Gene Transcription During Cardiac Development

Miao Cui, Ning Liu, Rhonda S. Bassel-Duby, Eric N. Olson

CIRCULATION RESEARCH (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

RBPMS, An RNA-binding Protein That Mediates Cardiomyocyte Binucleation And Cardiovascular Development

Peiheng Gan, Rhonda S. Bassel-Duby, Ning Liu, Eric N. Olson

CIRCULATION RESEARCH (2022)

暂无数据